They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH.
他们也设计了一个特殊的抑制物(小分子),它可以结合在人类DDAH的活性位点上。
This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease.
这个研究第一次说明ddah - 1酶活性的丧失导致NO产生的减少并且可能导致心脏和循环疾病。
Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk.
科学家假设,如果DDAH的功能被损害了,那么NO的产生也会减少,这可能是心血管疾病风险增加的一个重要特征。
应用推荐